NeuroMetrix, Inc. (NURO)’in fiyatı nedir?

NeuroMetrix, Inc. (NURO)’in fiyatı $4.58’dir

NeuroMetrix, Inc. (NURO)’in piyasa değeri nedir?

NeuroMetrix, Inc. (NURO)’in piyasa değeri $6.98M’dir.

NeuroMetrix, Inc. (NURO) Tedavüldeki Hisseler

NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing, and distributing medical devices that stimulate and evaluate nerve function for both diagnostic and therapeutic applications. These products are available across a wide geographical area, including the United States, Europe, Japan, China, the Middle East, and Mexico. The company's core offerings include DPNCheck, a nerve conduction test used to identify and assess peripheral neuropathies such as diabetic peripheral neuropathy; Quell, a wearable device engineered for the relief and management of persistent pain; and the ADVANCE system, a dedicated platform for performing comprehensive nerve conduction studies. NeuroMetrix supplies its advanced solutions to a diverse clientele, encompassing managed care organizations, primary care providers, specialists like endocrinologists, podiatrists, various surgeons (including orthopedic and hand surgeons), occupational health practitioners, and neurology, pain medicine, and physical medicine and rehabilitation experts. Incorporated in 1996, the company's headquarters are located in Woburn, Massachusetts.

Yıl	Tedavüldeki Hisse Sayısı	Değiştir
2026 (TTM)	2.05M	4.12%
2024	1.97M	89.16%
2023	1.04M	16.84%
2022	891.27K	-65.26%
2021	2.57M	-32.27%
2020	3.79M	218.80%
2019	1.19M	57.26%
2018	755.47K	344.01%
2017	170.15K	103.32%
2016	83.69K	65.42%
2015	50.59K	98.58%
2014	25.48K	37.13%
2013	18.58K	177.71%
2012	6.69K	233.33%
2011	2.01K	0.45%
2010	2.00K	37.23%
2009	1.46K	22.15%
2008	1.19K	8.76%
2007	1.10K	1.01%
2006	1.09K	2.94%
2005	1.05K	0.96%
2004	1.04K	3.98%
2003	1.00K	0.00%
2002	1.00K	0.00%
2001	1.00K	0.00%

Yıl

Tedavüldeki Hisse Sayısı

Değiştir

2026 (TTM)

2.05M

4.12%

2024

1.97M

89.16%

2023

1.04M

16.84%

2022

891.27K

-65.26%

2021

2.57M

-32.27%

2020

3.79M

218.80%

2019

1.19M

57.26%

2018

755.47K

344.01%

2017

170.15K

103.32%

2016

83.69K

65.42%

2015

50.59K

98.58%

2014

25.48K

37.13%

2013

18.58K

177.71%

2012

6.69K

233.33%

2011

2.01K

0.45%

2010

2.00K

37.23%

2009

1.46K

22.15%

2008

1.19K

8.76%

2007

1.10K

1.01%

2006

1.09K

2.94%

2005

1.05K

0.96%

2004

1.04K

3.98%

2003

1.00K

0.00%

2002

1.00K

0.00%

2001

1.00K

0.00%

Şirket	Tedavüldeki Hisse Sayısı	Fark	Ülke
Abbott Laboratories ABT.US	1.74B	84,884.21%	US
Stryker Corporation SYK.US	383.50M	18,597.94%	US
Medtronic plc MDT.US	1.28B	62,410.12%	IE
Boston Scientific Corporation BSX.US	1.48B	71,941.92%	US
Edwards Lifesciences Corporation EW.US	576.40M	28,002.98%	US

Şirket

Tedavüldeki Hisse Sayısı

Fark

Ülke